{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:43:33Z","timestamp":1648604613786},"reference-count":56,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,6,1]]},"abstract":"<jats:p>Ovulation induction is particularly challenging in patients with polycystic ovarian syndrome (PCOS) and may be complicated by multifollicular development. Pulsatile GnRH stimulates monofollicular development in women with anovulatory infertility; however, ovulation rates are considerably lower in the subgroup of patients with PCOS. The aim of this retrospective study was to determine specific hormonal, metabolic, and ovarian morphological characteristics that predict an ovulatory response to pulsatile GnRH therapy in patients with PCOS.<\/jats:p>\n               <jats:p>Subjects with PCOS were defined by chronic amenorrhea or oligomenorrhea and clinical and\/or biochemical hyperandrogenism in the absence of an adrenal or pituitary disorder. At baseline, gonadotropin dynamics were assessed by 10-min blood sampling, insulin resistance by fasting insulin levels, ovarian morphology by transvaginal ultrasound, and androgen production by total testosterone levels. Intravenous pulsatile GnRH was then administered. During GnRH stimulation, daily blood samples were analyzed for gonadotropins, estradiol (E2), progesterone, inhibin B, and androgen levels, and serial ultrasounds were performed.<\/jats:p>\n               <jats:p>Forty-one women with PCOS underwent a total of 144 ovulation induction cycles with pulsatile GnRH. Fifty-six percent of patients ovulated with 40% of ovulatory patients achieving pregnancy. Among the baseline characteristics, ovulatory cycles were associated with lower body mass index (P &amp;lt; 0.05), lower fasting insulin (P = 0.02), lower 17-hydroxyprogesterone and testosterone responses to hCG (P &amp;lt; 0.03) and higher FSH (P &amp;lt; 0.05). In the first week of pulsatile GnRH treatment, E2 and the size of the largest follicle were higher (P &amp;lt; 0.03), whereas androstenedione was lower (P &amp;lt; 0.01) in ovulatory compared with anovulatory patients. Estradiol levels of 230 pg\/mL (844 pmol\/L) or more and androstenedione levels of 2.5 ng\/mL (8.7 nmol\/L) or less on day 4 and follicle diameter of 11 mm or more by day 7 of pulsatile GnRH treatment had positive predictive values for ovulation of 86.4%, 88.4%, and 99.6%, respectively. Ovulatory patients who conceived had lower free testosterone levels at baseline (P &amp;lt; 0.04).<\/jats:p>\n               <jats:p>In conclusion, pulsatile GnRH is an effective and safe method of ovulation induction in a subset of patients with PCOS. Patient characteristics associated with successful ovulation in response to pulsatile GnRH include lower body mass index and fasting insulin levels, lower androgen response to hCG, and higher baseline FSH. In ovulatory patients, high free testosterone is negatively associated with pregnancy. A trial of pulsatile GnRH therapy may be useful in all PCOS patients, as E2 and androstenedione levels on day 4 or follicle diameter on day 7 of therapy are highly predictive of the ovulatory response in this group of patients.<\/jats:p>","DOI":"10.1210\/jcem.86.6.7538","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:53Z","timestamp":1389200813000},"page":"2428-2436","source":"Crossref","is-referenced-by-count":0,"title":["Specific Factors Predict the Response to Pulsatile Gonadotropin-Releasing Hormone Therapy in Polycystic Ovarian Syndrome1"],"prefix":"10.1210","volume":"86","author":[{"given":"Sabrina","family":"Gill","sequence":"first","affiliation":[{"name":"Reproductive Endocrine Unit and the National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann E.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and the National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Martin","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and the National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrine K.","family":"Welt","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and the National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Adams","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and the National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Hall","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and the National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071617555793000_R1","author":"Zawadzki","year":"1992"},{"key":"2020071617555793000_R2","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern US: a prospective study.","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0889-8529(05)70045-1","article-title":"Polycystic ovary syndrome.","volume":"27","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071617555793000_R4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0015-0282(16)54352-0","article-title":"Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.","volume":"55","author":"Anttila","year":"1991","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(99)00184-3","article-title":"Insulin, androgens and obesity in women with and without polycystic ovary syndrome: a heterogenous group of disorders.","volume":"72","author":"Acien","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.","volume":"1","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"2020071617555793000_R7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0015-0282(16)46034-6","article-title":"Clinical and laboratory predictors of clomiphene response.","volume":"37","author":"Lobo","year":"1982","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0015-0282(16)60423-5","article-title":"Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.","volume":"51","author":"Polson","year":"1989","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0015-0282(16)49878-X","article-title":"Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.","volume":"46","author":"Burger","year":"1986","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0029-7844(96)00190-1","article-title":"Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.","volume":"88","author":"Tan","year":"1996","journal-title":"Obstet Gynecol"},{"key":"2020071617555793000_R11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0015-0282(16)56751-X","article-title":"Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.","volume":"61","author":"Corenthal","year":"1994","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(16)59943-9","article-title":"Pulsatile luteinizing horone-releasing hormone therapy in women with polycystic ovary syndrome.","volume":"49","author":"Eshel","year":"1988","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","article-title":"Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotropin.","volume":"99","author":"Hamilton-Fairley","year":"1992","journal-title":"Br J Obstet Gynecol"},{"key":"2020071617555793000_R14","first-page":"189","volume":"83","author":"Fluker","year":"1994"},{"key":"2020071617555793000_R15","first-page":"3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.","volume":"81","author":"White","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0015-0282(16)57473-1","article-title":"A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.","volume":"63","author":"Homburg","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R17","first-page":"125","article-title":"Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.","volume":"77","author":"Martin","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/jcem-66-2-327","article-title":"Gonadotropin-releasing hormone analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.","volume":"66","author":"Filicori","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R20","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J"},{"key":"2020071617555793000_R23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2337\/diab.46.7.1167","article-title":"Differences between the tolbutabmide-boosted and the insulin-modified minimal model protocols.","volume":"46","author":"Saad","year":"1997","journal-title":"Diabetes"},{"key":"2020071617555793000_R24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jcem-62-1-109","article-title":"Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.","volume":"62","author":"Santoro","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-71-5-1081","article-title":"Clinical review 15: management of ovulatory disorders with pulsatile gonadotropin-releasing hormone.","volume":"71","author":"Martin","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R26","first-page":"2163","article-title":"Inhibin A and inhibin B responses to gonadotropin withdrawal depend on stage of follicle development.","volume":"84","author":"Welt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9378(87)90268-7","article-title":"Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome.","volume":"156","author":"Greenblatt","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"2020071617555793000_R28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM198005083021903","article-title":"The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.","volume":"302","author":"Crowley Jr.","year":"1980","journal-title":"N Engl J Med"},{"key":"2020071617555793000_R29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1172\/JCI111370","article-title":"Neuroendocrine regulation of the corpus luteum in the human.","volume":"73","author":"Filicori","year":"1984","journal-title":"J Clin Invest"},{"key":"2020071617555793000_R30","first-page":"240","article-title":"A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation.","volume":"79","author":"Taylor","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R31","first-page":"4103","article-title":"Ovarian 17-hydroxyprogesterone hyperresponsiveness to GnRH agonist challenge in women with polycystic ovary syndrome is not mediated by gonadotropin hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.","volume":"81","author":"Ibanez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R32","first-page":"3692","article-title":"Inhibin B in males with gonadotropin-releasing hormone deficiency: changes in serum concentration after short term physiologic GnRH replacement.","volume":"81","author":"Seminara","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R33","first-page":"428","article-title":"Impact of binge eating on metabolic and leptin dynamics in normal young women.","volume":"84","author":"Taylor","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R34","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1172\/JCI107454","article-title":"Episodic luteinizing hormone secretion in man: pulse analysis, clinical interpretation, and physiologic mechanism.","volume":"52","author":"Santen","year":"1973","journal-title":"J Clin Invest"},{"key":"2020071617555793000_R35","first-page":"1028","article-title":"Free \u03b1- subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies.","volume":"84","author":"Hayes","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-2607(86)90106-9","article-title":"MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.","volume":"23","author":"Pacini","year":"1986","journal-title":"Comput Methods Programs Biomed"},{"key":"2020071617555793000_R37","first-page":"1215","article-title":"Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles.","volume":"79","author":"Filicori","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.298.6676.809","article-title":"One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.","volume":"798","author":"Homburg","year":"1989","journal-title":"Br Med J"},{"key":"2020071617555793000_R39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0015-0282(16)55276-5","article-title":"Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome.","volume":"58","author":"McClure","year":"1992","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R40","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R41","first-page":"676","article-title":"Free androgen index and leptin are the most prominant endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.","volume":"85","author":"Imani","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0015-0282(16)56879-4","article-title":"Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction.","volume":"62","author":"Filicori","year":"1994","journal-title":"Fertil Steril"},{"key":"2020071617555793000_R43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/milmed\/161.12.732","article-title":"Metabolic parameters that predict response to clomiphene citrate in obese oligo-ovulatory women.","volume":"161","author":"Armstrong","year":"1996","journal-title":"Military Med"},{"key":"2020071617555793000_R44","first-page":"23","article-title":"Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene.","volume":"44","author":"Murakawa","year":"1999","journal-title":"J Reprod Med"},{"key":"2020071617555793000_R45","first-page":"347","article-title":"Serum insulin in clomiphene responders and nonresponders with polycystic ovarian disease.","volume":"47","author":"Espinosa de los Monteros","year":"1995","journal-title":"Rev Invest Clin"},{"key":"2020071617555793000_R46","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a116768","article-title":"How good a marker is insulin level for insulin resistance?","volume":"137","year":"1993","journal-title":"Am J Epidemiol"},{"key":"2020071617555793000_R47"},{"key":"2020071617555793000_R48","first-page":"4167","article-title":"Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle.","volume":"83","author":"Burger","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R49"},{"key":"2020071617555793000_R50","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.1998.00442.x","article-title":"Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.","volume":"48","author":"Anderson","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617555793000_R51","first-page":"2343","article-title":"Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.","volume":"83","author":"Hayes","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-69-4-825","article-title":"The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin- releasing hormone: characterization and management.","volume":"69","author":"Filicori","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617555793000_R53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/09513598909152449","article-title":"Endocrine dynamics during pulsatile GnRH administration in patients with hypothalamic amenorrhea and polycystic ovarian disease.","volume":"3","author":"Rossmanith","year":"1989","journal-title":"Gynecol Endocrinol"},{"key":"2020071617555793000_R54","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"key":"2020071617555793000_R55","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgen stimulates early stages of follicular growth in the primate ovary.","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071617555793000_R56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.83.1.4500","article-title":"Hormonal effects of flutamide in young women with polycystic ovary syndrome.","volume":"83","author":"De Leo","year":"1998","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/6\/2428\/9166669\/jcem2428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/6\/2428\/9166669\/jcem2428.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:40:15Z","timestamp":1594957215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/86\/6\/2428\/2848655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.86.6.7538","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,1]]}}}